ID   SCH9_YEAST              Reviewed;         824 AA.
AC   P11792; D3DLF4;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 3.
DT   07-APR-2021, entry version 209.
DE   RecName: Full=Serine/threonine-protein kinase SCH9;
DE            EC=2.7.11.1;
GN   Name=SCH9; Synonyms=KOM1; OrderedLocusNames=YHR205W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3290050; DOI=10.1101/gad.2.5.517;
RA   Toda T., Cameron S., Sass P., Wigler M.;
RT   "SCH9, a gene of Saccharomyces cerevisiae that encodes a protein distinct
RT   from, but functionally and structurally related to, cAMP-dependent protein
RT   kinase catalytic subunits.";
RL   Genes Dev. 2:517-527(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=JR26-19D;
RX   PubMed=8442384; DOI=10.1002/yea.320090104;
RA   di Blasi F., Carra E., de Vendittis E., Masturzo P., Burderi E.,
RA   Lambrinoudaki I., Mirisola M.G., Seidita G., Fasano O.;
RT   "The SCH9 protein kinase mRNA contains a long 5' leader with a small open
RT   reading frame.";
RL   Yeast 9:21-32(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8091229; DOI=10.1126/science.8091229;
RA   Johnston M., Andrews S., Brinkman R., Cooper J., Ding H., Dover J., Du Z.,
RA   Favello A., Fulton L., Gattung S., Geisel C., Kirsten J., Kucaba T.,
RA   Hillier L.W., Jier M., Johnston L., Langston Y., Latreille P., Louis E.J.,
RA   Macri C., Mardis E., Menezes S., Mouser L., Nhan M., Rifkin L., Riles L.,
RA   St Peter H., Trevaskis E., Vaughan K., Vignati D., Wilcox L., Wohldman P.,
RA   Waterston R., Wilson R., Vaudin M.;
RT   "Complete nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   VIII.";
RL   Science 265:2077-2082(1994).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-723 AND SER-726, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [7]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-570; SER-711; THR-723; SER-726;
RP   THR-737; SER-758 AND SER-765.
RX   PubMed=17560372; DOI=10.1016/j.molcel.2007.04.020;
RA   Urban J., Soulard A., Huber A., Lippman S., Mukhopadhyay D., Deloche O.,
RA   Wanke V., Anrather D., Ammerer G., Riezman H., Broach J.R., De Virgilio C.,
RA   Hall M.N., Loewith R.;
RT   "Sch9 is a major target of TORC1 in Saccharomyces cerevisiae.";
RL   Mol. Cell 26:663-674(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17287358; DOI=10.1073/pnas.0607084104;
RA   Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L.,
RA   Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.;
RT   "Analysis of phosphorylation sites on proteins from Saccharomyces
RT   cerevisiae by electron transfer dissociation (ETD) mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-726, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-723 AND SER-726, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [11]
RP   FUNCTION.
RX   PubMed=20702584; DOI=10.1091/mbc.e10-03-0182;
RA   Soulard A., Cremonesi A., Moes S., Schutz F., Jeno P., Hall M.N.;
RT   "The rapamycin-sensitive phosphoproteome reveals that TOR controls protein
RT   kinase A toward some but not all substrates.";
RL   Mol. Biol. Cell 21:3475-3486(2010).
CC   -!- FUNCTION: Protein kinase that is part of growth control pathway which
CC       is at least partially redundant with the cAMP pathway. Regulates both
CC       BCY1 phosphorylation and MPK1 activity (PubMed:20702584). Regulates
CC       ribosome biogenesis, translation initiation, and entry into stationary
CC       phase in a TORC1-dependent manner (PubMed:17560372).
CC       {ECO:0000269|PubMed:17560372, ECO:0000269|PubMed:20702584}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Activated by cAMP.
CC   -!- MISCELLANEOUS: Present with 3850 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-2 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB69735.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X12560; CAA31073.1; -; Genomic_DNA.
DR   EMBL; X57629; CAA40853.1; -; Genomic_DNA.
DR   EMBL; U00029; AAB69735.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BK006934; DAA06898.1; -; Genomic_DNA.
DR   PIR; S48986; S48986.
DR   RefSeq; NP_012075.1; NM_001179336.1.
DR   SMR; P11792; -.
DR   BioGRID; 36639; 696.
DR   ELM; P11792; -.
DR   IntAct; P11792; 10.
DR   MINT; P11792; -.
DR   STRING; 4932.YHR205W; -.
DR   iPTMnet; P11792; -.
DR   MaxQB; P11792; -.
DR   PaxDb; P11792; -.
DR   PRIDE; P11792; -.
DR   EnsemblFungi; YHR205W_mRNA; YHR205W; YHR205W.
DR   GeneID; 856612; -.
DR   KEGG; sce:YHR205W; -.
DR   SGD; S000001248; SCH9.
DR   VEuPathDB; FungiDB:YHR205W; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   GeneTree; ENSGT00940000168810; -.
DR   HOGENOM; CLU_000288_52_2_1; -.
DR   InParanoid; P11792; -.
DR   OMA; HMDDEFV; -.
DR   BRENDA; 2.7.11.1; 984.
DR   Reactome; R-SCE-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-SCE-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-SCE-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-SCE-165158; Activation of AKT2.
DR   Reactome; R-SCE-198693; AKT phosphorylates targets in the nucleus.
DR   Reactome; R-SCE-203615; eNOS activation.
DR   Reactome; R-SCE-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-SCE-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-SCE-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-SCE-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-SCE-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-SCE-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-SCE-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-SCE-9009391; Extra-nuclear estrogen signaling.
DR   Reactome; R-SCE-9031628; NGF-stimulated transcription.
DR   PRO; PR:P11792; -.
DR   Proteomes; UP000002311; Chromosome VIII.
DR   RNAct; P11792; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0000329; C:fungal-type vacuole membrane; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:SGD.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:1904828; P:positive regulation of hydrogen sulfide biosynthetic process; IMP:SGD.
DR   GO; GO:0060963; P:positive regulation of ribosomal protein gene transcription by RNA polymerase II; IMP:SGD.
DR   GO; GO:0045943; P:positive regulation of transcription by RNA polymerase I; IMP:SGD.
DR   GO; GO:0045945; P:positive regulation of transcription by RNA polymerase III; IMP:SGD.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:SGD.
DR   GO; GO:0008361; P:regulation of cell size; HMP:SGD.
DR   GO; GO:1901494; P:regulation of cysteine metabolic process; IMP:SGD.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:SGD.
DR   GO; GO:0047484; P:regulation of response to osmotic stress; IMP:SGD.
DR   GO; GO:0090153; P:regulation of sphingolipid biosynthetic process; IMP:SGD.
DR   GO; GO:0043619; P:regulation of transcription from RNA polymerase II promoter in response to oxidative stress; IMP:SGD.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00168; C2; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; cAMP; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..824
FT                   /note="Serine/threonine-protein kinase SCH9"
FT                   /id="PRO_0000086638"
FT   DOMAIN          166..378
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          412..671
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          672..748
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   NP_BIND         418..426
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   COMPBIAS        227..267
FT                   /note="Asn-rich"
FT   ACT_SITE        538
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         441
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         570
FT                   /note="Phosphothreonine; by PKH1 or PKH2"
FT                   /evidence="ECO:0000269|PubMed:17560372"
FT   MOD_RES         711
FT                   /note="Phosphoserine; by TORC1"
FT                   /evidence="ECO:0000269|PubMed:17560372"
FT   MOD_RES         723
FT                   /note="Phosphothreonine; by TORC1"
FT                   /evidence="ECO:0000269|PubMed:17560372,
FT                   ECO:0007744|PubMed:17330950, ECO:0007744|PubMed:19779198"
FT   MOD_RES         726
FT                   /note="Phosphoserine; by TORC1"
FT                   /evidence="ECO:0000269|PubMed:17560372,
FT                   ECO:0007744|PubMed:17330950, ECO:0007744|PubMed:18407956,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         737
FT                   /note="Phosphothreonine; by TORC1"
FT                   /evidence="ECO:0000269|PubMed:17560372"
FT   MOD_RES         758
FT                   /note="Phosphoserine; by TORC1"
FT                   /evidence="ECO:0000269|PubMed:17560372"
FT   MOD_RES         765
FT                   /note="Phosphoserine; by TORC1"
FT                   /evidence="ECO:0000269|PubMed:17560372"
FT   CONFLICT        366
FT                   /note="I -> S (in Ref. 1; CAA31073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        751
FT                   /note="N -> K (in Ref. 1; CAA31073)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   824 AA;  91812 MW;  BA84BE0F27143AB5 CRC64;
     MMNFFTSKSS NQDTGFSSQH QHPNGQNNGN NNSSTAGNDN GYPCKLVSSG PCASSNNGAL
     FTNFTLQTAT PTTAISQDLY AMGTTGITSE NALFQMKSMN NGISSVNNNN SNTPTIITTS
     QEETNAGNVH GDTGGNSLQN SEDDNFSSSS TTKCLLSSTS SLSINQREAA AAAYGPDTDI
     PRGKLEVTII EARDLVTRSK DSQPYVVCTF ESSEFISNGP ESLGAINNNN NNNNNNQHNQ
     NQHINNNNEN TNPDAASQHH NNNSGWNGSQ LPSIKEHLKK KPLYTHRSSS QLDQLNSCSS
     VTDPSKRSSN SSSGSSNGPK NDSSHPIWHH KTTFDVLGSH SELDISVYDA AHDHMFLGQV
     RLYPMIHNLA HASQHQWHSL KPRVIDEVVS GDILIKWTYK QTKKRHYGPQ DFEVLRLLGK
     GTFGQVYQVK KKDTQRIYAM KVLSKKVIVK KNEIAHTIGE RNILVTTASK SSPFIVGLKF
     SFQTPTDLYL VTDYMSGGEL FWHLQKEGRF SEDRAKFYIA ELVLALEHLH DNDIVYRDLK
     PENILLDANG NIALCDFGLS KADLKDRTNT FCGTTEYLAP ELLLDETGYT KMVDFWSLGV
     LIFEMCCGWS PFFAENNQKM YQKIAFGKVK FPRDVLSQEG RSFVKGLLNR NPKHRLGAID
     DGRELRAHPF FADIDWEALK QKKIPPPFKP HLVSETDTSN FDPEFTTAST SYMNKHQPMM
     TATPLSPAMQ AKFAGFTFVD ESAIDEHVNN NRKFLQNSYF MEPGSFIPGN PNLPPDEDVI
     DDDGDEDIND GFNQEKNMNN SHSQMDFDGD QHMDDEFVSG RFEI
//
